For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders
Henry, Rebecca J. Kerr, Daniel M. Finn, David P. Roche, Michelle
Henry, Rebecca J.
Kerr, Daniel M.
Finn, David P.
Roche, Michelle
Loading...
Publication Date
2015-03-17
Type
Article
Downloads
Citation
Henry, Rebecca J., Kerr, Daniel M., Finn, David P., & Roche, Michelle. (2016). For whom the endocannabinoid tolls: Modulation of innate immune function and implications for psychiatric disorders. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 64, 167-180. doi: https://doi.org/10.1016/j.pnpbp.2015.03.006
Abstract
Toll-like receptors (TLRs) mediate the innate immune response to pathogens and are critical in the host defence, homeostasis and response to injury. However, uncontrolled and aberrant TLR activation can elicit potent effects on neurotransmission and neurodegenerative cascades and has been proposed to trigger the onset of certain neurodegenerative disorders and elicit detrimental effects on the progression and outcome of established disease. Over the past decade, there has been increasing evidence demonstrating that the endocannabinoid system can elicit potent modulatory effects on inflammatory processes, with clinical and preclinical evidence demonstrating beneficial effects on disease severity and symptoms in several inflammatory conditions. This review examines the evidence supporting a modulatory effect of endocannabinoids on TLR-mediated immune responses both peripherally and centrally, and the implications for psychiatric disorders such as depression and schizophrenia. (C) 2015 Elsevier Inc. All rights reserved.
Funder
Publisher
Elsevier
Publisher DOI
Rights
Attribution-NonCommercial-NoDerivs 3.0 Ireland